Atlas Trials

Change in Quality of Life After Addition of Weekly 40 mg Pegvisomant/Placebo in Controlled Acromegalic Patients

Clinical trial NCT00642720 · COMPLETED

Trial details

NCT number
NCT00642720
Sponsor
Erasmus Medical Center
Status
COMPLETED
Phase
Phase 4
Study type
INTERVENTIONAL
Quality of LifeAcromegaly
Start date
2006-10-01
Primary completion
2007-07-01
Enrollment
20

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.